| Date | Time | Source | Headline | Symbol | Company |
| 17/11/2017 | 21:07 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 14/11/2017 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 09/11/2017 | 22:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 22:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 22:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 22:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 22:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 22:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 22:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 22:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 22:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 22:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 22:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 16:01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 15:24 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 14:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 14:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 14:18 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 14:17 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 14:15 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 13:57 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 07/11/2017 | 13:43 | GlobeNewswire Inc. | Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 06/11/2017 | 21:08 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 27/10/2017 | 22:04 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 26/10/2017 | 13:55 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 26/10/2017 | 13:48 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 26/10/2017 | 13:30 | GlobeNewswire Inc. | Ultragenyx and Dimension Announce Expiration of Hart-Scott-Rodino Waiting Period for Ultragenyx’s Acquisition of Dimension | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 23/10/2017 | 16:15 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 23/10/2017 | 16:11 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |
| 17/10/2017 | 15:38 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:DMTX | Dimension Therapeutics, Inc. |